X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
female (91) 91
index medicus (90) 90
male (81) 81
adult (75) 75
infectious diseases (68) 68
thailand (64) 64
adolescent (48) 48
middle aged (42) 42
aids vaccines - immunology (39) 39
tropical medicine (37) 37
hiv-1 - immunology (35) 35
immunology (35) 35
thailand - epidemiology (34) 34
infection (33) 33
research (33) 33
hiv (32) 32
infections (32) 32
vaccines (32) 32
hiv infections - immunology (29) 29
risk factors (29) 29
public health (28) 28
hiv antibodies - immunology (26) 26
young adult (26) 26
aids (24) 24
hiv envelope protein gp120 - immunology (24) 24
hiv infections - prevention & control (24) 24
human immunodeficiency virus--hiv (23) 23
viruses (23) 23
cross-sectional studies (22) 22
parasitology (22) 22
research article (21) 21
acquired immune deficiency syndrome--aids (20) 20
antibodies (20) 20
health aspects (20) 20
hiv-1 (20) 20
malaria (20) 20
public, environmental & occupational health (20) 20
virology (20) 20
aged (19) 19
medicine (19) 19
child (18) 18
surveys and questionnaires (18) 18
vaccination (18) 18
aids vaccines - administration & dosage (17) 17
animals (17) 17
analysis (16) 16
retrospective studies (16) 16
child, preschool (15) 15
clinical trials (15) 15
aids vaccines (14) 14
arctic medicine. tropical medicine (14) 14
efficacy (14) 14
efficacy trial (14) 14
hiv antibodies - blood (14) 14
immunodeficiency-virus type-1 (14) 14
immunoglobulin g - immunology (14) 14
infant (14) 14
medical research (14) 14
parasitic diseases (14) 14
transmission (14) 14
treatment outcome (14) 14
binding (13) 13
health knowledge, attitudes, practice (13) 13
microbiology (13) 13
prevention (13) 13
science (13) 13
armed forces (12) 12
epidemiology (12) 12
infectious and parasitic diseases (12) 12
multidisciplinary sciences (12) 12
socioeconomic factors (12) 12
studies (12) 12
surveillance (12) 12
acquired immune deficiency syndrome (11) 11
article (11) 11
human immunodeficiency virus (11) 11
immunoglobulins (11) 11
medicine, research & experimental (11) 11
time factors (11) 11
usage (11) 11
vector-borne diseases (11) 11
virus diseases (11) 11
aged, 80 and over (10) 10
antibodies, monoclonal - immunology (10) 10
biology and life sciences (10) 10
care and treatment (10) 10
children (10) 10
drug resistance (10) 10
gp120 (10) 10
hiv infections - epidemiology (10) 10
human-immunodeficiency-virus (10) 10
immunization (10) 10
tuberculosis (10) 10
amino acid sequence (9) 9
cell biology (9) 9
disease transmission (9) 9
epitopes (9) 9
ethics (9) 9
hiv infection (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 23, pp. 2209 - 2220
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2019, Volume 14, Issue 10, p. e0223619
Questions have been raised over the acceptability of conducting human challenge studies in low and middle income countries (LMICs). Most of these concerns are... 
Studies | Surveys | Ethics | Community involvement | Safety engineering | Income | Research facilities | Informed consent | Community relations | Zika virus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1275 - 1286
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2013, Volume 110, Issue 22, pp. 9019 - 9024
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 833 - 842
Summary Background The emergence of highly pathogenic avian influenza H5N1 viruses has raised concerns about their pandemic potential. Vaccination is the most... 
Infectious Disease | A H5N1 | INFECTIOUS DISEASES | IMMUNE-RESPONSES | CLINICAL-TRIALS | HUMANS | ADULTS | PHASE-I | Influenza Vaccines - administration & dosage | Humans | Middle Aged | Male | Neutralization Tests | Healthy Volunteers | Thailand | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Hemagglutination Inhibition Tests | Young Adult | Influenza A Virus, H5N2 Subtype - immunology | Vaccines, Attenuated - administration & dosage | Adult | Female | Placebos - administration & dosage | Double-Blind Method | Influenza Vaccines - adverse effects | Injections, Intramuscular | Administration, Intranasal | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Attenuated - immunology | Animals | Influenza Vaccines - immunology | Influenza A Virus, H5N1 Subtype - immunology | Adolescent | T-Lymphocytes - immunology | Vaccines, Attenuated - adverse effects | Influenza, Human - prevention & control | Antibodies, Neutralizing - blood | Plasma Cells - immunology | Influenza vaccines | Clinical trials | Influenza | Shedding | Epidemics | Immunological memory | Immunization | Immune response | Pandemics | Vaccination | Helper cells | Antibodies | Priming | Viruses | Vaccines | Avian flu | Randomization | Immunogenicity | Workers | Long term memory | Adults | Inhibition | Safety | Index Medicus
Journal Article
Journal Article
Immunity, ISSN 1074-7613, 01/2013, Volume 38, Issue 1, pp. 176 - 186
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e87572
In the RV144 HIV-1 vaccine efficacy trial, IgG antibody (Ab) binding levels to variable regions 1 and 2 (V1V2) of the HIV-1 envelope glycoprotein gp120 were an... 
V1/V2 DOMAIN | B-CELL RESPONSES | MULTIDISCIPLINARY SCIENCES | ENVELOPE | SEQUENCE | REACTIVITY | BROAD | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | NEUTRALIZATION | EPITOPES | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Statistics, Nonparametric | Placebos | Adult | Female | HIV Envelope Protein gp120 - chemistry | Odds Ratio | Amino Acid Sequence | Enzyme-Linked Immunosorbent Assay | Risk Factors | Treatment Outcome | HIV-1 - immunology | HIV Antigens - immunology | Adolescent | HIV Antigens - chemistry | Cluster Analysis | Antigen-antibody reactions | Antigens | Immunoglobulin G | HIV testing | Vaccines | HIV (Viruses) | Health aspects | Risk factors | Enzyme-linked immunosorbent assay | Biopharmaceutics | Multiplexing | Plasma | Correlation | IgG antibody | Laboratories | Identification methods | Viruses | Infections | Assaying | Proteins | Ethics | Regression models | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Public health | Binding | Medical research | Immunization | Immunoglobulins | Cross-reactivity | Glycoprotein | Health risks | Glycoproteins | Regression analysis | Dentistry | Virology | Medicine | Injections | Infectious diseases | Reagents | Scaffolds | Glycoprotein gp120 | Cancer | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 8/2012, Volume 206, Issue 3, pp. 431 - 441
Journal Article